Last reviewed · How we verify
NCT04670848
Contactless Detection of Sleep Apnea
NA trial testing Sleepiz One+ vs. polysomnography in Sleep Apnea in 116 participants. Completed in 21 December 2021.
21 December 2021
Quick facts
| Lead sponsor | Sleepiz AG |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | non randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | diagnostic |
| Enrollment | 116 |
| Start date | 7 December 2020 |
| Primary completion | 21 December 2021 |
| Estimated completion | 21 December 2021 |
| Sites | 1 location across Germany |
Drugs / interventions tested
- Sleepiz One+ vs. polysomnography
Conditions studied
- Sleep Apnea — all drugs for Sleep Apnea →
Sponsor
Sleepiz AG
Who can join
18 and older, any sex, with Sleep Apnea. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
In this study the inestigators aim to validate the performance of Sleepiz One+ for sleep apnea detection during routine diagnostic sleep studies. Patients who are prescribed polysomnography study will be asked to participate and undergo a simultaneous sleep recording with radar sensor-based device.
Publications & conference data
2 peer-reviewed publications reference this trial (live from Europe PMC):
-
Validation of the Sleepiz One + as a radar-based sensor for contactless diagnosis of sleep apnea.
Gross-Isselmann JA, Eggert T, Wildenauer A, Dietz-Terjung S, et al · · 2024 · cited 9× · PMID 38744804 · DOI 10.1007/s11325-024-03057-6 -
Long-term night-to-night variability of sleep-disordered breathing using a radar-based home sleep apnea test: a prospective cohort study.
Tschopp S, Borner U, Caversaccio M, Tschopp K. · · 2024 · cited 6× · PMID 38415722 · DOI 10.5664/jcsm.11070
Verify or expand the search:
- PubMed search for NCT04670848
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Sleep Apnea
Currently open trials in the same condition.
- NCT07086742 — Validation of the Smart Mask V1 System and Its Measurements of SpO2 and Pulse Rate · NA · recruiting
- NCT07243405 — Neurostimulation for Sleep Disordered Breathing (SDB) · NA · recruiting
- NCT06931028 — A Study of IBI362 in Chinese Subjects With Obstructive Sleep Apnea and BMI≥28 kg/m2 · Phase 3 · recruiting
- NCT06649929 — Nuestro Sueno: Cultural Adaptation of a Couples Intervention to Improve PAP Adherence and Sleep Health Among Latino Coup · Phase 2 · recruiting
- NCT06755840 — Sleep Disordered Breathing and Multimorbidity: The Xiangya SDB Cohort Study · recruiting
Other Sleepiz AG trials
Trials by the same sponsor.
- NCT06569940 — Sleepiz One+ vs. Capnography and Electrocardiography · NA · recruiting
- NCT05712226 — Sleepiz One+ Versus Capnography and Electrocardiography · NA · completed
- NCT04803552 — Non-contact Sleep Apnea Identification in Neurological Rehabilitation · NA · unknown
- NCT04676191 — Validation of a Contactless Vital Signs Measurement Sensor · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04670848 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Sleepiz AG
- Last refreshed: 25 January 2022
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04670848.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing